SBI Securities »

Aptevo Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $292 31 9.42

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Tesla Motors (TSLA)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
Alphabet Inc Class C cs (GOOG)
SPDR Gold MiniShares Trust Etf (GLDM)

View all positions for SBI Securities

Top funds holding Aptevo Therapeutics

Vanguard Group
Advisor Group Holdings
UBS Group
Tower Research Capital
SBI Securities
Tradewinds Capital Management
CWM
Danske Bank A/s

View all funds holding Aptevo Therapeutics